AJP - Cell Physiology, Vol 264, Issue 6 C1600-C1608, Copyright © 1993 by American Physiological Society

ARTICLES

Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells

T. Sandouk, D. Reda and C. Hofmann
Department of Molecular and Cellular Biochemistry, Loyola University Stritch School of Medicine, Maywood 60153.

Adipocytes play an important role in normal physiology as a major site for systemic energy homeostasis. In disorders such as diabetes, adipocyte function is markedly altered. In this study, we investigated the effect of pioglitazone, a novel antidiabetic agent known to lower plasma glucose in animal models of diabetes mellitus, on cellular differentiation and expression of adipose-specific genes. Treatment of confluent 3T3-F442A preadipocyte cultures for 7 days with pioglitazone (Pio; 1 microM) and insulin (Ins; 0.17 microM) resulted in > 95% cell differentiation into lipid-accumulating adipocytes in comparison with 60-80% cell differentiation by treatment with either agent alone. Analysis of triglyceride accumulation showed increases of triglyceride content over time above untreated preadipocytes by treatment of the cells with Ins, Pio, and especially with Ins + Pio. Basal glucose transport, as measured by cellular uptake of 2-deoxy-D-[14C]glucose, was likewise enhanced in a time-dependent manner by treatment of preadipocytes with Ins, Pio, or Ins + Pio, such that a synergistic effect resulted from the combined treatment with both agents. It was further determined that RNA transcript abundance for genes encoding glucose transporters GLUT-1 and GLUT-4, as well as the adipose-specific genes encoding adipsin and aP2, were increased by the Ins, Pio, or Ins + Pio treatment. Taken together, these findings indicate that pioglitazone is a potent adipogenic agent. By promoting differentiation, this agent may move cells into a state active for glucose uptake, storage, and metabolism.

This article has been cited by other articles:

				E. D. Rosen, C. J. Walkey, P. Puigserver, and B. M. Spiegelman Transcriptional regulation of adipogenesis Genes & Dev., June 1, 2000; 14(11): 1293 - 1307. [Full Text]

				F. J. King, E. Hu, D. F. Harris, P. Sarraf, B. M. Spiegelman, and T. M. Roberts DEF-1, a Novel Src SH3 Binding Protein That Promotes Adipogenesis in Fibroblastic Cell Lines Mol. Cell. Biol., March 1, 1999; 19(3): 2330 - 2337. [Abstract] [Full Text] [PDF]

				S. Ranganathan and P. A. Kern Thiazolidinediones Inhibit Lipoprotein Lipase Activity in Adipocytes J. Biol. Chem., October 2, 1998; 273(40): 26117 - 26122. [Abstract] [Full Text] [PDF]

				S. Mandrup, R. V. Sorensen, T. Helledie, J. Nohr, T. Baldursson, C. Gram, J. Knudsen, and K. Kristiansen Inhibition of 3T3-L1 Adipocyte Differentiation by Expression of Acyl-CoA-binding Protein Antisense RNA J. Biol. Chem., September 11, 1998; 273(37): 23897 - 23903. [Abstract] [Full Text] [PDF]

				F. M. GREGOIRE, C. M. SMAS, and H. S. SUL Understanding Adipocyte Differentiation Physiol Rev, July 1, 1998; 78(3): 783 - 809. [Abstract] [Full Text] [PDF]

				G. Martin, K. Schoonjans, A.-M. Lefebvre, B. Staels, and J. Auwerx Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARalpha and PPARgamma Activators J. Biol. Chem., November 7, 1997; 272(45): 28210 - 28217. [Abstract] [Full Text] [PDF]

				A.-M. Lefebvre, J. Peinado-Onsurbe, I. Leitersdorf, M. R. Briggs, J. R. Paterniti, J.-C. Fruchart, C. Fievet, J. Auwerx, and B. Staels Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1756 - 1764. [Abstract] [Full Text]

				J. M. Lehmann, J. M. Lenhard, B. B. Oliver, G. M. Ringold, and S. A. Kliewer Peroxisome Proliferator-activated Receptors alpha and gamma Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs J. Biol. Chem., February 7, 1997; 272(6): 3406 - 3410. [Abstract] [Full Text] [PDF]

				Y. Guan, Y. Zhang, A. Schneider, L. Davis, R. M. Breyer, and M. D. Breyer Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1036 - F1046. [Abstract] [Full Text] [PDF]